FindTrial
Sign In

hearing assesment in patients on antitubercular treatment

Hearing assesment in multidrug resistant tuberculosis patients undergoing antitubercular treatment using otoacoustic emissions:a hospital based study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/111424
Enrollment
55
Registered
2026-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J989- Respiratory disorder, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: nil: nil

Sponsors

Dr Vaibhavi Arya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: new multidrug resistant pulmonary tuberculosis patients

Exclusion criteria

Exclusion criteria: participants with evidence of hearing loss prior to study

Design outcomes

Primary

MeasureTime frame
prevention of hearing lossTimepoint: 4 weeks—

Secondary

MeasureTime frame
Intervention of hearing impairment caused by antitubercular treatmentTimepoint: 18 months—

Countries

India

Contacts

Public ContactDr Shahzad Ahmad

Government medical college Haldwani

drshahzadjnmch85@gmail.com9634623901

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026